US 9815825
Coumarin derivatives and methods of use in treating cystic fibrosis, chronic obstructive pulmonary disease, and misfolded protein disorders
granted A61PA61P11/00A61P11/12
Quick answer
US patent 9815825 (Coumarin derivatives and methods of use in treating cystic fibrosis, chronic obstructive pulmonary disease, and misfolded protein disorders) held by DISCOVERYBIOMED, INC. expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DISCOVERYBIOMED, INC.
- Grant date
- Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P11/00, A61P11/12, A61P43/00